These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2328208)

  • 1. Effect of 5-fluorouracil combination therapy on RNA processing in human colonic carcinoma cells.
    Greenhalgh DA; Parish JH
    Br J Cancer; 1990 Mar; 61(3):415-9. PubMed ID: 2328208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-fluorouracil on cytotoxicity and RNA metabolism in human colonic carcinoma cells.
    Greenhalgh DA; Parish JH
    Cancer Chemother Pharmacol; 1989; 25(1):37-44. PubMed ID: 2591000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Jpn J Cancer Res; 2000 Nov; 91(11):1192-8. PubMed ID: 11092986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.
    Benz C; Choti M; Newcomer L; Cadman E
    Cancer Chemother Pharmacol; 1984; 12(2):104-10. PubMed ID: 6199130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
    Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
    Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
    Zupi G; Marangolo M; Arancia G; Greco C; Laudonio N; Iosi F; Formisano G; Malorni W
    Cancer Res; 1988 Nov; 48(21):6193-200. PubMed ID: 3167866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
    Kopper L; Magyarosy E; Jeney A; Lapis K; Szabolcs A; Otvös L
    Oncology; 1984; 41(3):155-8. PubMed ID: 6328393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro.
    Kanamaru R; Kakuta H; Sato T; Ishioka C; Wakui A
    Cancer Chemother Pharmacol; 1986; 17(1):43-6. PubMed ID: 3698176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo.
    Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P
    Cancer Chemother Pharmacol; 1996; 37(3):259-65. PubMed ID: 8529287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.
    Ghoshal K; Jacob ST
    Cancer Res; 1994 Feb; 54(3):632-6. PubMed ID: 8306322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical modulation of 5-FU by thymidine and N-phosphoacetyl-L-aspartate: the relation between 5-FU incorporation into RNA and its cytocidal effect].
    Akazawa S; Kumai R; Shimizu K; Ayusawa D; Seno T; Yoshida S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):990-5. PubMed ID: 3963863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
    Ishii T; Marumo K
    Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical modulation of 5-fluorouracil with a streptococcal preparation, OK-432, against murine colon-26 carcinoma.
    Funaki M; Gouchi A; Iwagaki H; Morimoto Y; Shimamura H; Ariki N; Tanaka N
    Acta Med Okayama; 2000 Oct; 54(5):217-25. PubMed ID: 11061571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity.
    Peters GJ; Laurensse E; Leyva A; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1869-81. PubMed ID: 3436351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
    Wadler S; Mao X; Bajaj R; Hallam S; Schwartz EL
    Mol Pharmacol; 1993 Nov; 44(5):1070-6. PubMed ID: 8246910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.